Skip to main content
Clinical Trials/NCT02154711
NCT02154711
Completed
Not Applicable

Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease

University of Pennsylvania1 site in 1 country40 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitochondrial Disease
Sponsor
University of Pennsylvania
Enrollment
40
Locations
1
Primary Endpoint
Creatine Recovery Time
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of the study is to use a new research imaging technique, a kind of magnetic resonance imaging (MRI), to measure important metabolic features of muscle, including mitochondrial function, in people with mitochondrial disease and in healthy individuals. (Mitochondria are tiny organelles that generate energy for the body.)

It is hoped that this new strategy will help physicians to understand better the health problems of people with mitochondrial disease. Eventually, this could lead to better diagnostic and treatment approaches.

Detailed Description

There are two study-related visits. The first visit is a "screening" visit to ensure eligibility. This includes fasting blood tests. The second visit is an MRI scanning session. This also takes around 2 - 3 hours, with no more than 1.5 hours spent in the actual MRI machine. It may be possible to complete these two visits on the same day. Otherwise, the MRI session should occur within 3 months of the screening visit. In addition, an optional physical capacity visit will occur on the same day as the MRI session.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
June 30, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shana McCormack

Instructor in Pediatrics

University of Pennsylvania

Eligibility Criteria

Inclusion Criteria

  • Genetic diagnosis of mitochondrial disease
  • Be able to perform sub-maximal leg exercise for several minutes
  • Be able to provide written, informed consent
  • Cognitively and medically stable and able to comply with study procedures
  • Able to fast for 4 hours prior to blood draw and/or MRI scanning
  • Be willing to stop taking any over-the-counter vitamins and supplements that are neither prescribed nor recommend by their physician for 2 weeks prior to MRI scanning

Exclusion Criteria

  • Alcohol/substance abuse
  • Use of any investigational agents within 4 weeks of enrollment
  • Any contraindication to MRI scanning
  • Group 2) Healthy Individuals:
  • Inclusion Criteria:
  • Be able to perform sub-maximal leg exercise for several minutes
  • Be able to provide written, informed consent
  • Cognitively and medically stable and able to comply with study procedures
  • Able to fast for 4 hours prior to blood draw and/or MRI scanning
  • Be willing to stop taking any over-the-counter vitamins and supplements that are neither prescribed nor recommend by their physician for 2 weeks prior to MRI scanning

Outcomes

Primary Outcomes

Creatine Recovery Time

Time Frame: 15 minutes

Secondary Outcomes

  • Phosphocreatine recovery time(15 minutes)

Study Sites (1)

Loading locations...

Similar Trials